Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Net Cash Flow (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Net Cash Flow for 3 consecutive years, with -$3.6 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow changed N/A to -$3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$3.3 million for FY2025, N/A changed from the prior year.
  • Net Cash Flow for Q4 2025 was -$3.6 million at Adagio Medical Holdings, up from -$7.5 million in the prior quarter.
  • The five-year high for Net Cash Flow was $2.7 million in Q1 2024, with the low at -$7.5 million in Q1 2025.
  • Average Net Cash Flow over 3 years is -$3.0 million, with a median of -$2.8 million recorded in 2024.
  • Peak annual rise in Net Cash Flow hit 382.62% in 2025, while the deepest fall reached 382.62% in 2025.
  • Over 3 years, Net Cash Flow stood at -$542000.0 in 2023, then crashed by 1179.7% to -$6.9 million in 2024, then soared by 47.42% to -$3.6 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$3.6 million, -$7.5 million, and -$6.9 million for Q4 2025, Q1 2025, and Q3 2024 respectively.